Bernhard Lämmle spends much of his time researching Thrombotic thrombocytopenic purpura, Von Willebrand factor, Immunology, Internal medicine and Platelet. His Thrombotic thrombocytopenic purpura research focuses on subjects like Hemolytic anemia, which are linked to Vascular disease. His Von Willebrand factor research is multidisciplinary, incorporating elements of Molecular biology and Protease.
His Immunology research focuses on Thrombotic microangiopathy and how it relates to Hematopoietic stem cell transplantation, Schistocyte and Microangiopathic hemolytic anemia. His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Surgery. His Platelet research is multidisciplinary, incorporating perspectives in Stop codon, Gene, Allele and Thrombus.
His primary areas of study are Internal medicine, Thrombotic thrombocytopenic purpura, Immunology, Gastroenterology and ADAMTS13. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Surgery and Cardiology. His study looks at the intersection of Thrombotic thrombocytopenic purpura and topics like Autoantibody with Immunoglobulin G.
His Immunology and Von Willebrand factor, Platelet, Antibody, Acquired Thrombotic Thrombocytopenic Purpura and Antigen investigations all form part of his Immunology research activities. The study incorporates disciplines such as Protease and Fresh frozen plasma in addition to Von Willebrand factor. His primary area of study in ADAMTS13 is in the field of Congenital Thrombotic Thrombocytopenic Purpura.
Bernhard Lämmle mainly focuses on Internal medicine, Thrombotic thrombocytopenic purpura, ADAMTS13, Gastroenterology and Thrombotic microangiopathy. His study in Internal medicine is interdisciplinary in nature, drawing from both Prekallikrein and Allele. His Thrombotic thrombocytopenic purpura study results in a more complete grasp of Immunology.
His studies in Immunology integrate themes in fields like Subclinical infection and Zebrafish. His work is dedicated to discovering how ADAMTS13, Rituximab are connected with Fresh frozen plasma and other disciplines. His Gastroenterology research includes elements of Purpura, Congenital Thrombotic Thrombocytopenic Purpura and Iron deficiency, Intravenous iron.
Bernhard Lämmle focuses on Internal medicine, Thrombotic thrombocytopenic purpura, ADAMTS13, Thrombosis and Rituximab. His research brings together the fields of Gastroenterology and Internal medicine. His Thrombotic thrombocytopenic purpura study is focused on Immunology in general.
While the research belongs to areas of Thrombosis, Bernhard Lämmle spends his time largely on the problem of Neutrophil extracellular traps, intersecting his research to questions surrounding Stroke, Myocardial infarction, Ischemia, Venous thrombosis and Leukocytosis. His research in Microangiopathic hemolytic anemia tackles topics such as Thrombotic microangiopathy which are related to areas like Intensive care medicine. Bernhard Lämmle has researched Cohort study in several fields, including Pulmonary embolism, Surgery, Cancer and Venous thromboembolism.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
Miha Furlan;Rodolfo Robles;Miriam Galbusera;Giuseppe Remuzzi.
The New England Journal of Medicine (1998)
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis
Miha Furlan;Rodolfo Robles;Bernhard Lammle.
ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients
Sara K. Vesely;James N. George;Bernhard Lämmle;Jan Dirk Studt.
Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
Miha Furlan;Rodolfo Robles;Max Solenthaler;Max Wassmer.
Survival and relapse in patients with thrombotic thrombocytopenic purpura.
Johanna A. Kremer Hovinga;Sara K. Vesely;Deirdra R. Terrell;Bernhard Lämmle.
Partial amino acid sequence of purified von Willebrand factor-cleaving protease.
Helena E. Gerritsen;Rodolfo Robles;Bernhard Lämmle;Miha Furlan.
Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)
Helena E. Gerritsen;Peter L. Turecek;Hans P. Schwarz;Bernhard Lämmle.
Thrombosis and Haemostasis (1999)
Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura
Miha Furlan;Rodolfo Robles;Max Solenthaler;Bernhard Lämmle.
Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura.
Valentina Bianchi;Rodolfo Robles;Lorenzo Alberio;Miha Furlan.
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.
D. R. Terrell;L. A. Williams;S. K. Vesely;B. Lämmle.
Journal of Thrombosis and Haemostasis (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: